McDermott Will & Emery has advised Great Point Partners on the transaction. Great Point Partners (GPP) announced the acquisition of German-based drug product contract development and...
Great Point Partners’ Acquisition of Lyocontract
Robert Bosch GmbH’s Acquisition of Paladin Technologies
McDermott Will & Emery represented affiliates of Robert Bosch GmbH in the transaction. Robert Bosch GmbH (Bosch), a leading global supplier of technology and services, announced...
Speyside Equity’s Continuation Vehicle Transaction With Opta Group
McDermott Will & Emery represented Speyside Equity Fund I LP and Speyside Equity Opportunity Fund LP in the transaction. Debevoise & Plimpton acted as legal counsel...
BeatStars’ Strategic Partnership with Lemonaide
Cooley advised Lemonaide on the deal. BeatStars announced its strategic alliance with Lemonaide. The partnership between Lemonaide and BeatStars is compelling because of both companies’ shared commitment...
RoslinCT’s Merger with Lykan Bioscience
Ropes & Gray and Slaughter & May acted as legal advisors to GHO, while McDermott Will & Emery LLP advised WindRose Health Investors, LLC. RoslinCT entered into...
Vivitide’s Business Combination With Biosynth Carbosynth
McDermott Will & Emery represented Ampersand Capital Partners in the transaction. Ampersand Capital Partners, a healthcare-focused private equity fund, and KKR, a leading global investment firm, finalized...
Merck KGaA’s Out-Licensing Agreement for Osteoarthritis Asset Sprifermin
McDermott Will & Emery represented Merck KGaA on the deal. Merck KGaA, Darmstadt, Germany, a leading science and technology company, through its subsidiary Ares Trading S.A.,...